During the previous week, the robot successfully generated a gain of +3.93% while trading TDOC (Teladoc Health Inc.), a medium volatility stock favored for active trading. Despite this commendable performance, recent technical indicators and earnings results indicate potential challenges ahead. In this article, we will analyze the bearish signals triggered by TDOC's Moving Average Convergence Divergence Histogram (MACD) and examine the company's latest earnings report.
Bearish Signal:
MACD Turns Negative On June 23, 2023, TDOC's MACD turned negative, signaling a potential decline in the stock's price. The MACD is a widely-used technical indicator that helps traders identify trend reversals and market momentum. Tickeron's A.I.dvisor, a renowned AI-driven investment analysis tool, has examined 49 instances where the MACD turned negative. In 44 out of the 49 cases, the stock experienced subsequent declines. This statistical analysis indicates a 90% likelihood of TDOC moving downward in the coming days.
Earnings Report Overview:
TDOC's most recent earnings report, released on April 26, revealed an earnings per share (EPS) of -41 cents. While this figure represents a loss, it surpassed analysts' estimates of -50 cents. A better-than-expected EPS suggests that the company's financial performance exceeded market expectations. However, it is important to note that TDOC's earnings report is slightly dated, and investors should consider the latest market conditions and factors influencing the stock's performance.
Market Capitalization and Shares Outstanding:
With 267.25K shares outstanding, TDOC's current market capitalization stands at 3.90 billion dollars. Market capitalization is a key metric used to assess the overall value of a company and determine its relative size in the market. TDOC's market capitalization indicates its significance within the healthcare sector and the broader stock market.
While Swing Trader's AI robot achieved an impressive gain of +3.93% trading TDOC last week, caution is warranted due to the bearish signals triggered by the stock's MACD turning negative. Tickeron's A.I.dvisor's analysis, based on historical data, suggests a 90% probability of a downward move in the stock's price. Additionally, TDOC's most recent earnings report exceeded analysts' estimates, signaling positive financial performance.
The 10-day RSI Indicator for TDOC moved out of overbought territory on November 06, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In 22 of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TDOC as a result. In 75 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The Moving Average Convergence Divergence Histogram (MACD) for TDOC turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 40 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TDOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
TDOC moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TDOC crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.
The 50-day moving average for TDOC moved above the 200-day moving average on November 09, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +12.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where TDOC advanced for three days, in 183 of 259 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
TDOC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 135 of 181 cases where TDOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
The Tickeron Valuation Rating of 18 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.216) is normal, around the industry mean (4.523). P/E Ratio (-8.859) is within average values for comparable stocks, (12.601). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.536). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.462) is also within normal values, averaging (6.105).
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. TDOC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TDOC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a telephone and online video consultation service
Industry ServicestotheHealthIndustry